Dec 17,2019

Pear Therapeutics Announces First Patient Dosed in Part II of Pear-006 Feasibility Study to Treat Depressive Symptoms in People with Multiple Sclerosis

Pear Therapeutics today announced the first patient dosed in part II of the first clinical study evaluating Pear-006, a digital therapeutic product candidate for addressing depressive symptoms in Multiple Sclerosis (MS). The randomized controlled trial will enroll approximately 30 patients with Relapsing MS for eight weeks treatment with digital therapy and evaluate dosing, patient use, engagement, and other clinical outcomes.

PRODUCT

#pdt

#cbt

View Analyst & Ambassador Comments
Go to original news
Nov 08,2019

How VR, AR could support astronauts' mental health in space

NASA stakeholders discuss the potential for technologies supporting astronauts' mental health and cognitive functioning during a mission. Dr. Adam Gazzaley, cofounder of digital therapeutics startup Akilli Interactive Labs and executive director of the University of California, San Francisco's Neuroscape lab, has been working on combining rhythm and VR into a game that could stimulate brain activity.

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Feb 06,2019

Big Health follows up Sleepio with Daylight, an app for anxiety

Big Health, the London and San Francisco-based digital health app company behind CBT-based sleep app Sleepio, has released its second app, Daylight, which is focused on combating worry and anxiety. Like Sleepio, the app is based on cognitive behavioral therapy. It was developed by a group of creatives the company describes as "leading podcast producers, filmmakers, designers and animators, including veterans of Pixar and NPR’s Radiolab", with scientific support from Boston University, University of California, Los Angeles, University of Oxford and University of Texas, Austin.

PRODUCT

#mobile app

#cbt

View Analyst & Ambassador Comments
Go to original news
Mar 27,2019

SilverCloud and Washington University School of Medicine Explore The Effectiveness Of The Company’s Digital Behavioral Health Therapy Product

Digital behavioral health company SilverCloud has entered a research partnership with the Washington University School of Medicine in St. Louis that will explore the effectiveness of the company’s digital behavioral health therapy product for depression, anxiety and eating disorders among students. The project will be led by the university professor Denise E. Wilfley, who received a five-year $3.8 million grant from the National Institute of Mental Health for this type of research.

COLLABORATION PARTNERSHIP

#institution

#pdt

View Analyst & Ambassador Comments
Go to original news
Apr 11,2019

Digital mental health tools won't see clinical adoption without validation, industry players say

There is an app for just about everything, and the mental health space is no different. But industry experts warn that not all mental health apps are created equally. While there are exemplars of tools that have been clinically validated, there is also a slew of technologies that have not been tested at all.

#mobile app

#pdt

View Analyst & Ambassador Comments
Go to original news
May 24,2019

NightWare Awarded FDA “Breakthrough Status” for PTSD Apple Watch App

NightWare, Inc., digital therapeutics for mental health company has received Breakthrough Status designation from the U.S. Food and Drug Administration (FDA) for its NightWare Apple Watch app that measures and treats nightmares in people with Post-Traumatic Stress Disorder (PTSD).

REGULATORY FDA

#mobile app

#connected device

View Analyst & Ambassador Comments
Go to original news
May 28,2019

SilverCloud Health Teams Up with Ontario Shores Centre for Mental Health Sciences on a New Initiative

Digital behavioral health company SilverCloud Health is teaming up with Ontario Shores Centre for Mental Health Sciences on a new digital therapeutic initiative, which employs the former's mental health platform. As part of the deal patients with anxiety or depression will be offered SilverCloud’s tool. The program will be offered to individuals receiving care in the outpatient setting, and includes teens, adults and seniors.

COLLABORATION PARTNERSHIP

#institution

#mobile app

#cbt

View Analyst & Ambassador Comments
Go to original news
Jun 26,2019

Blue Shield of California Launches Digital Therapeutics Platform At No Cost to Members

Blue Shield of California is launching a new digital therapeutics platform that will provide programs to eligible members at no cost to them. Powered by Solera Health, the new Wellvolution platform provides curated, scientific and results-based digital programs that can be personalized to each of its members’ individual health needs and preferences. The program is available at no cost to members enrolled in Blue Shield’s fully insured employer-sponsored plans or it’s Individual and Family Plans.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Sep 19,2019

Sanofi targets digital by cutting new deals with Abbott, Happify

Sanofi has been active in the digital space this week inking two big deals: one with tech company Abbott and the other with digital platform Happify. Sanofi’s deal with Happify is focused on treating multiple sclerosis symptoms, in particular anxiety and depression. The pair are collaborating on a digital therapeutic app to help people manage and improve their psychological outcomes. The plan is to develop and test the app in clinical trials before seeking FDA clearance.

COLLABORATION PARTNERSHIP

#r&d

#mobile app

#software

View Analyst & Ambassador Comments
Go to original news
Sep 27,2019

Ieso Launches Eight Billion Minds to Address Unmet Global Mental Health Needs

Ieso Digital Health, a leader in internet-enabled cognitive behavioural therapy (IECBT), launches Eight Billion Minds, a new digital therapeutics program aiming to address the global and regional shortages of mental health therapists. Eight Billion Minds is building the next generation of mental healthcare based on analysis of real-world clinical data from Ieso’s IECBT platform, ThinkWell™, with a vision to make mental health treatments accessible for all. The company has decoded what works in real-world clinical settings and plans to use new technology to distribute highly personalized therapies on a scale that is just not possible in 1:1 delivery.

PRODUCT

#cbt

View Analyst & Ambassador Comments
Go to original news
Subscribe to MENTAL HEALTH